Skip to main content
Erschienen in: Clinical Drug Investigation 5/2011

01.05.2011 | Original Research Article

Potential Drug-Drug Interactions Associated with Prolonged Stays in the Intensive Care Unit

A Retrospective Cohort Study

verfasst von: Prof. Cristiano Moura, Nília Prado, Francisco Acurcio

Erschienen in: Clinical Drug Investigation | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Background and Objectives: Drug-drug interactions (DDIs) are one cause of adverse drug events and can cause harm to hospitalized patients. Little has been done to study the relationship between potential DDIs and an increased length of stay (LOS) in the intensive care unit (ICU). The aim of this study was to determine the frequency of potential DDIs during ICU stays and to determine whether the frequency of these adverse events was associated with ICU LOS.
Methods: This retrospective cohort study was conducted from January to December 2007 in the ICU of the General Hospital of Vitória da Conquista, Brazil. The study population comprised all patients aged >18 years admitted to the hospital’s ICU. Demographic and prescription data were collected from medical files. All prescriptions administered during the period were examined. Potential DDIs were identified and classified according to the book Drug Interaction Facts. The median LOS was determined by the Kaplan-Meier method and Cox proportional hazards models were fitted to analyse the relationship between potential DDIs and the LOS.
Results: The study population comprised 236 adults, 158 (67%) of them men, between the ages of 18 and 96 years, with a mean ± SD age of 50 ± 20 years. The median LOS among patients with at least one DDI was 12 days compared with 5 days among those with no DDIs (p<0.01). Multiple Cox proportional regression analyses showed that a prolonged ICU stay was positively associated with DDIs (hazard ratio [HR] 0.54; 95% CI 0.37, 0.80; p<0.01), where an HR <1 indicates a variable that increases the risk of prolonged stay (i.e. an adverse outcome). This association was true even after controlling for the cost of hospitalization, the number of procedures and the number of prescribed drugs.
Conclusion: In this study, DDIs were found to be associated with a longer ICU stay. Given that LOS is an important indicator of the quality of health care delivered and that DDIs are considered avoidable, specific measures are necessary to increase the recognition of DDIs. E-prescriptions and dispensing programmes associated with a DDI knowledge base can help health professionals identify hazardous drug combinations.
Literatur
1.
Zurück zum Zitat Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001 Mar–Apr; 41(2): 192–9 Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001 Mar–Apr; 41(2): 192–9
2.
Zurück zum Zitat Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997 Jan 22–29; 277(4): 301–6PubMedCrossRef Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997 Jan 22–29; 277(4): 301–6PubMedCrossRef
3.
Zurück zum Zitat Jankel CA, Speedie SM. Detecting drug interactions: a review of the literature. DICP 1990 Oct; 24(10): 982–9PubMed Jankel CA, Speedie SM. Detecting drug interactions: a review of the literature. DICP 1990 Oct; 24(10): 982–9PubMed
4.
Zurück zum Zitat Heininger-Rothbucher D, Bischinger S, Ulmer H, et al. Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation 2001 Jun; 49(3): 283–8PubMedCrossRef Heininger-Rothbucher D, Bischinger S, Ulmer H, et al. Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation 2001 Jun; 49(3): 283–8PubMedCrossRef
5.
Zurück zum Zitat Janchawee B, Wongpoowarak W, Owatranporn T, et al. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther 2005 Feb; 30(1): 13–20PubMedCrossRef Janchawee B, Wongpoowarak W, Owatranporn T, et al. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther 2005 Feb; 30(1): 13–20PubMedCrossRef
6.
Zurück zum Zitat Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci 2006; 9(3): 427–33PubMed Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci 2006; 9(3): 427–33PubMed
7.
Zurück zum Zitat Glintborg B, Andersen SE, Dalhoff K. Drug-drug interactions among recently hospitalised patients: frequent but mostly clinically insignificant. Eur J Clin Pharmacol 2005 Oct; 61(9): 675–81PubMedCrossRef Glintborg B, Andersen SE, Dalhoff K. Drug-drug interactions among recently hospitalised patients: frequent but mostly clinically insignificant. Eur J Clin Pharmacol 2005 Oct; 61(9): 675–81PubMedCrossRef
8.
Zurück zum Zitat Riechelmann RP, Zimmermann C, Chin SN, et al. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 2008 May; 35(5): 535–43PubMedCrossRef Riechelmann RP, Zimmermann C, Chin SN, et al. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 2008 May; 35(5): 535–43PubMedCrossRef
9.
Zurück zum Zitat Hammes JA, Pfuetzenreiter F, da Silveira F, et al. Potential drug interactions prevalence in intensive care units. Rev Bras Ter Intensiva 2008; 20(4): 349–54CrossRef Hammes JA, Pfuetzenreiter F, da Silveira F, et al. Potential drug interactions prevalence in intensive care units. Rev Bras Ter Intensiva 2008; 20(4): 349–54CrossRef
10.
Zurück zum Zitat Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ 1996 Apr 15; 154(8): 1177–84PubMed Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ 1996 Apr 15; 154(8): 1177–84PubMed
11.
Zurück zum Zitat Egger SS, Ratz Bravo AE, Hess L, et al. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins. Drugs Aging 2007; 24(5): 429–40PubMedCrossRef Egger SS, Ratz Bravo AE, Hess L, et al. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins. Drugs Aging 2007; 24(5): 429–40PubMedCrossRef
12.
Zurück zum Zitat Gagne JJ, Maio V, Rabinowitz C. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 2008 Apr; 33(2): 141–51PubMedCrossRef Gagne JJ, Maio V, Rabinowitz C. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 2008 Apr; 33(2): 141–51PubMedCrossRef
13.
Zurück zum Zitat World Health Organization (WHO). International classification of diseases. 10th rev. ed. WHO: Geneva, 1994 World Health Organization (WHO). International classification of diseases. 10th rev. ed. WHO: Geneva, 1994
14.
Zurück zum Zitat Ramiarina RA, Ramiarina BL, Almeida RM, et al. Comorbidity adjustment index for the International Classification of Diseases, 10th rev. Rev Saude Publica 2008 Aug; 42(4): 590–7PubMedCrossRef Ramiarina RA, Ramiarina BL, Almeida RM, et al. Comorbidity adjustment index for the International Classification of Diseases, 10th rev. Rev Saude Publica 2008 Aug; 42(4): 590–7PubMedCrossRef
15.
Zurück zum Zitat Portela MC, Schramm JM, Pepe VL, et al. Algorithm for establishing hospital admittance data based on the hospital information system in the Brazilian Unified Health System. Cad Saude Publica 1997 Oct; 13(4): 771–4PubMedCrossRef Portela MC, Schramm JM, Pepe VL, et al. Algorithm for establishing hospital admittance data based on the hospital information system in the Brazilian Unified Health System. Cad Saude Publica 1997 Oct; 13(4): 771–4PubMedCrossRef
16.
Zurück zum Zitat Tatro D. Drug interaction facts 2007: facts and comparisons. St Louis (MO): Wolters Kluwer Health Inc., 2007 Tatro D. Drug interaction facts 2007: facts and comparisons. St Louis (MO): Wolters Kluwer Health Inc., 2007
17.
Zurück zum Zitat Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics 1982 Mar; 38: 29–41CrossRef Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics 1982 Mar; 38: 29–41CrossRef
18.
Zurück zum Zitat Vargas E, Simon J, Martin JC, et al. Effect of adverse drug reactions on length of stay in intensive care units. Clin Drug Investig 1998; 15(4): 353–60PubMedCrossRef Vargas E, Simon J, Martin JC, et al. Effect of adverse drug reactions on length of stay in intensive care units. Clin Drug Investig 1998; 15(4): 353–60PubMedCrossRef
19.
Zurück zum Zitat Sierra P, Castillo J, Gomez M, et al. Potential and real drug interactions in critical care patients. Rev Esp Anestesiol Reanim 1997 Dec; 44(10): 383–7PubMed Sierra P, Castillo J, Gomez M, et al. Potential and real drug interactions in critical care patients. Rev Esp Anestesiol Reanim 1997 Dec; 44(10): 383–7PubMed
20.
Zurück zum Zitat Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985 Oct; 13(10): 818–29PubMedCrossRef Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985 Oct; 13(10): 818–29PubMedCrossRef
21.
Zurück zum Zitat Lemeshow S, Le Gall JR. Modeling the severity of illness of ICU patients: a systems update. JAMA 1994 Oct 5; 272(13): 1049–55PubMedCrossRef Lemeshow S, Le Gall JR. Modeling the severity of illness of ICU patients: a systems update. JAMA 1994 Oct 5; 272(13): 1049–55PubMedCrossRef
22.
Zurück zum Zitat Schneitman-McIntire O, Farnen TA, Gordon N, et al. Medication misadventures resulting in emergency department visits at an HMO medical center. Am J Health Syst Pharm 1996 Jun 15; 53(12): 1416–22PubMed Schneitman-McIntire O, Farnen TA, Gordon N, et al. Medication misadventures resulting in emergency department visits at an HMO medical center. Am J Health Syst Pharm 1996 Jun 15; 53(12): 1416–22PubMed
23.
Zurück zum Zitat McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002 Sep; 36(9): 1331–6PubMedCrossRef McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002 Sep; 36(9): 1331–6PubMedCrossRef
Metadaten
Titel
Potential Drug-Drug Interactions Associated with Prolonged Stays in the Intensive Care Unit
A Retrospective Cohort Study
verfasst von
Prof. Cristiano Moura
Nília Prado
Francisco Acurcio
Publikationsdatum
01.05.2011
Verlag
Springer International Publishing
Erschienen in
Clinical Drug Investigation / Ausgabe 5/2011
Print ISSN: 1173-2563
Elektronische ISSN: 1179-1918
DOI
https://doi.org/10.1007/BF03256929

Weitere Artikel der Ausgabe 5/2011

Clinical Drug Investigation 5/2011 Zur Ausgabe